(AGENPARL) – SILVER SPRING lun 03 aprile 2023 PD similarity studies rely on PD biomarkers, which are biological molecules that signal a normal or abnormal process. PD biomarkers can demonstrate a drug’s pharmacological (or treatment-related) effect.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/pharmacodynamic-biomarkers-their-role-biosimilar-product-development